Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies.

Cojutti, Pier Giorgio

Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies. [electronic resource] - British journal of clinical pharmacology 11 2018 - 2544-2550 p. digital

Publication Type: Journal Article

1365-2125

10.1111/bcp.13707 doi


Antifungal Agents--administration & dosage
Delayed-Action Preparations
Drug Interactions
Drug Monitoring--methods
Female
Glucocorticoids--administration & dosage
Graft vs Host Disease--therapy
Hematologic Neoplasms--therapy
Hematopoietic Stem Cell Transplantation--methods
Humans
Invasive Fungal Infections--prevention & control
Male
Middle Aged
Proton Pump Inhibitors--administration & dosage
Retrospective Studies
Risk Factors
Tablets
Triazoles--administration & dosage